US2018211722A1
|
|
Insulin activity map
|
CA2985362A1
|
|
Cholesterol efflux capacity assessment
|
US2016327578A1
|
|
Cholesterol efflux capacity assessment
|
US2014088073A1
|
|
Methods for determining whether a patient should be administered a drug that inhibits cholesterol absorption
|
US2015031058A1
|
|
Driving patient compliance with therapy
|
US2014088072A1
|
|
Methods for determining LDL cholesterol treatment
|
US2013248370A1
|
|
Methods for separation and immuno-detection of biomolecules, and apparatus related thereto
|
US2014120559A1
|
|
Diabetes panel
|
CA2851838A1
|
|
Compositions and methods for treating and preventing coronary heart disease
|
AU2011261480A1
|
|
Predicting plaque composition and phenotype in coronary arteries via HDL-subclass analysis, and methods related thereto
|